Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Hockey Stick" may Strike Back: Hepatocellular Carcinoma on Noncirrhotic Liver as a Late Toxicity of Lombo-Aortic Radiotherapy for Seminoma. A Review Triggered by an Unusual Case.1 passage
• 2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.1 passage
• 2D Shear Wave Elastography of Liver in Patients with Primary Extrahepatic Portal Vein Obstruction.1 passage
• A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy.1 passage
• A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.1 passage
• A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome.1 passage
• A Dynamic Definition of Acute Kidney Injury Does not Improve Prognosis Assessment in Acutely Decompensated Patients with Cirrhosis.1 passage
• A Long-Term Prospective Study of Quality of Life, Abdominal Symptoms, and Cosmesis of Donors After Hepatectomy for Live-Donor Liver Transplantation.1 passage
• A Nationwide Analysis of Budd-Chiari Syndrome in the United States.1 passage
• A Novel Phosphoinositide-3-kinase Adapter Protein 1 Gene Missense Mutation in Familial Cirrhosis.1 passage
• A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.1 passage
• A Rare Case of Primary Sarcomatous Hepatocellular Carcinoma Without Previous Anticancer Therapy.1 passage
• A Rare Presentation of Leishmaniasis.1 passage
• A Study of Prevalence of Occult Hepatitis B Virus Infection, Knowledge and Preventive Practices Against Hepatitis B Virus in Barbers Serving the Armed Forces.1 passage
• A case series of amoebic liver abscess in patients with COVID-19 infection.1 passage
• A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis.1 passage
• Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.1 passage
• Accuracy of the Simplified Criteria for Autoimmune Hepatitis in Children: Systematic Review and Decision Analysis.1 passage
• Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.1 passage
• Acute Liver Failure of Non-A-E Viral Hepatitis Etiology-Profile, Prognosis, and Predictors of Outcome.1 passage
• Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for Statins.1 passage
• Acute Pancreatitis Complicating Liver Transplantation in a Case of Fulminant Hepatic Failure Due to Yellow Phosphorus Poisoning.1 passage
• Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion.1 passage
• Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.1 passage
• Acute liver failure secondary to yellow phosphorus rodenticide poisoning: Outcomes at a center with dedicated liver intensive care and transplant unit.1 passage
• Acute on Chronic Liver Failure-In-Hospital Predictors of Mortality in ICU.1 passage
• Acute on Chronic Liver Failure-What is in a 'Definition'?1 passage
• Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".1 passage
• Acute-on-Chronic Liver Failure: Etiology of Chronic and Acute Precipitating Factors and Their Effect on Mortality.1 passage
• Acute-on-Chronic Liver Failure: Recent Concepts.1 passage
• Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial.1 passage
• Adipocyte Fatty Acid-Binding Protein as a Predictor of Outcome in Alcohol-induced Acute-On-Chronic Liver Failure.1 passage
• Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children.1 passage
• Admission Serum Urea is a Better Predictor of Mortality than Creatinine in Patients With Acute-On-Chronic Liver Failure and Acute Kidney Injury.1 passage
• Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?1 passage
• An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease.1 passage
• Angioembolization of Post-traumatic Intrahepatic Arterioportal Fistula Presenting With Portal Hypertension.1 passage
• Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease.1 passage
• Approach to clinical syndrome of jaundice and encephalopathy in tropics.1 passage
• Autoimmune Hepatitis: Diagnostic Dilemma When It Is Disguised as Iron Overload Syndrome.1 passage
• Awareness and Concerns Among Adult Liver Transplant Recipients in the Current Pandemic Caused by Novel Coronavirus (COVID-19): Strategies to Safeguard a High-risk Population.1 passage
• Balloon-Occluded Retrograde Transvenous Obliteration (BRTO): A Novel Method of Control of Bleeding from Post-Glue Ulcer over Gastric Varices. Report of Two Cases and Review of Literature.1 passage
• Bilateral Adnexal Masses in a Young Female: Rare Presentation of Hepatocellular Carcinoma With Review of the Literature.1 passage
• Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.1 passage
• Blood Group Antigen Expression in Isolated Human Liver Cells in Preparation for Implementing Clinical ABO-Incompatible Hepatocyte Transplantation.1 passage
• Bone Health and Impact of Tenofovir Treatment in Men with Hepatitis-B Related Chronic Liver Disease.1 passage
• Brain Edema in Chronic Hepatic Encephalopathy.1 passage
• Brain Microstructural Correlates of Cognitive Dysfunction in Clinically and Biochemically Normal Hepatitis C Virus Infection.1 passage
• Budd-Chiari Syndrome With Spontaneous Intrahepatic Portosystemic Shunts: A Case Series.1 passage
• COVID-19 Vaccines in Patients With Chronic Liver Disease.1 passage
• COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!1 passage
• COVID-19 and short and medium-term outcomes in liver transplant patients: A spanish single-center case series.1 passage
• Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?1 passage
• Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis.1 passage
• Celiac Disease and Portal Hypertension: A Causal Association or Just a Coincidence?1 passage
• Cerebral Blood Flow and Metabolism in Hepatic Encephalopathy-A Meta-Analysis.1 passage
• Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.1 passage
• Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort.1 passage
• Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma.1 passage
• Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure.1 passage
• Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults?1 passage
• Cholemic or Bile Cast Nephropathy in a Child with Liver Failure.1 passage
• Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?1 passage
• Chronic Hepatitis E With Genotype 1-Masquerading as Allograft Rejection After LiverTransplantation.1 passage
• Cirrhotic Patients Have Worse Bowel Preparation at Screening Colonoscopy than Chronic Liver Disease Patients without Cirrhosis.1 passage
• Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy.1 passage
• Clinical Significance of Quantitative HBsAg Titres and its Correlation With HBV DNA Levels in the Natural History of Hepatitis B Virus Infection.1 passage
• Clinical and Molecular Risk Factors of Anti-tubercular Therapy Induced Hepatitis.1 passage
• Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.1 passage
• Clinical neurophysiology of hepatic encephalopathy.1 passage
• Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance.1 passage
• Coffee and Liver Disease.1 passage
• Combined Balloon-, Plug- and Coil-assisted Retrograde Transvenous Obliteration of Multiple Portosystemic Shunts to Treat Recurrent Hepatic Encephalopathy: A Case Report.1 passage
• Comparative Study of Community Acquired and Nosocomial Spontaneous Bacterial Peritonitis and its Variants in 150 Patients.1 passage
• Comparative Study of Ultrasound-guided Percutaneous Omental Biopsy in Cirrhotics and Noncirrhotics.1 passage
• Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma.1 passage
• Comparison of Elastography Point Quantification with Transient Elastography in Patients with Chronic Viral Hepatitis and Nonalcoholic Fatty Liver Disease: A Pilot Study.1 passage
• Complications of Catheter Drainage for Amoebic Liver Abscess.1 passage
• Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients.1 passage
• Correlation of baseline Portal pressure (hepatic venous pressure gradient) and Indocyanine Green Clearance Test With Post-transarterial Chemoembolization Acute Hepatic Failure.1 passage
• Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Expt Hepatol 9 (2019) 625-651].1 passage
• Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians.1 passage
• Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India.1 passage
• Could Stem Cell Therapy be the Cure in Liver Cirrhosis?1 passage
• Cross-sectional Imaging of Gallbladder Carcinoma: An Update.1 passage
• Current Diagnosis and Classification of Hepatic Encephalopathy.1 passage
• Cyproterone Acetate-Induced Acute Liver Failure: A Case Report and Review of the Literature.1 passage
• Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management.1 passage
• De Novo Autoimmune Hepatitis After Living Donor Liver Transplantation: A Series of 4 Cases.1 passage
• De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.1 passage
• Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix.1 passage
• Definition and nomenclature of hepatic encephalopathy.1 passage
• Delayed Graft Dysfunction due to Invasive Hepatic Mucormycosis After Living Donor Liver Transplantation.1 passage
• Delirium Tremens: Assessment and Management.1 passage
• Dengue Virus Transmission from Living Donor to Recipient in Liver Transplantation: A Case Report.1 passage
• Determinants of Medication Adherence in Liver Transplant Recipients.1 passage
• Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids.1 passage
• Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.1 passage
• Diagnosis of minimal hepatic encephalopathy.1 passage
• Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.1 passage
• Difficult to Treat Recurrent Pyogenic Cholangitis With Portal Pylephlebitis in the Setting of Idiopathic CD4+ Lymphocytopaenia.1 passage
• Digital Image Analysis has an Additive Beneficial Role to Conventional Cytology in Diagnosing the Nature of Biliary Ducts Stricture.1 passage
• Do Recipients of Genetically Related Donors Have Better Outcomes After Living Donor Liver Transplantation?1 passage
• Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.1 passage
• Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments.1 passage
• Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges.1 passage
• Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.1 passage
• Early Acute Severe HCV Recurrence After Transplantation: From Universal Mortality to Cure.1 passage
• Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.1 passage
• Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.1 passage
• Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?1 passage
• Effect of Donor Hepatic Steatosis on Ischemia Reperfusion Injury in Liver Transplant Recipient.1 passage
• Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis.1 passage
• Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India.1 passage
• Efficacy and Safety of Sofosbuvir-Based Direct Acting Antivirals for Hepatitis C in Septuagenarians and Octogenarians.1 passage
• Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.1 passage
• Encephalopathy in Wilson disease: copper toxicity or liver failure?1 passage
• Endoscopic Cyanoacrylate Glue Injection in Management of Gastric Variceal Bleeding: US Tertiary Care Center Experience.1 passage
• Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration: A New Modality to Diagnose Peritoneal Tuberculosis in Presence of Decompensated Cirrhosis-A Case Series and Review of Literature.1 passage
• Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.1 passage
• Enucleation Sign: A Computed Tomographic Appearance of Ruptured Hepatocellular Carcinoma.1 passage
• Ethnicity and Insurance-Specific Disparities in the Model for End-Stage Liver Disease Score at Time of Liver Transplant Waitlist Registration and its Impact on Mortality.1 passage
• Ethnicity-Specific Differences in Liver Transplant Outcomes Among Adults With Primary Sclerosing Cholangitis: 2005-2017 United Network for Organ Sharing/Organ Procurement and Transplantation Network.1 passage
• Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker.1 passage
• Evaluation of Splenic Stiffness in Patients of Extrahepatic Portal Vein Obstruction Using 2D Shear Wave Elastography: Comparison with Intra-Operative Portal Pressure.1 passage
• Evaluation of liver histopathological findings of COVID-19 by minimally invasive autopsies.1 passage
• Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.1 passage
• Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma.1 passage
• Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review.1 passage
• Extrahepatic Malignancies and Liver Transplantation: Current Status.1 passage
• Factors Affecting Psychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient.1 passage
• Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression.1 passage
• Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis.1 passage
• Fusion Image-Guided and Ultrasound-Guided Fine Needle Aspiration in Patients With Suspected Hepatic Metastases.1 passage
• Gastric Varices in Cirrhosis vs. Extrahepatic Portal Venous Obstruction and Response to Endoscopic1 passage
• Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review.1 passage
• Gastrointestinal and Liver Manifestations of COVID-19.1 passage
• Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.1 passage
• Genotype 1 and 3 Response to Velpatasvir and Sofosbuvir in Chronic Hepatitis C in the Kashmiri Population: An Observational Study.1 passage
• Giant Intrahepatic Portal Vein Aneurysm: Leave it or Treat it?1 passage
• Gilbert's Syndrome, Bilirubin Level and1 passage
• Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.1 passage
• Granulocyte Colony-Stimulating Factor Use in Decompensated Cirrhosis: Lack of Survival Benefit.1 passage
• Granulomatous Tubercular Hepatitis Presenting as Secondary Hemophagocytic Lymphohistiocytosis: A Case Report and Systematic Review of the Literature.1 passage
• Gut Microbiota in Alcoholic Hepatitis is Disparate from Those in Acute Alcoholic Pancreatitis and Biliary Disease.1 passage
• Gut microbiota: its role in hepatic encephalopathy.1 passage
• HBsAg Level as Predictor of Liver Fibrosis in HBeAg Positive Patients With Chronic Hepatitis B Virus Infection.1 passage
• Handgrip Strength as an Important Bed Side Tool to Assess Malnutrition in Patient with Liver Disease.1 passage
• Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.1 passage
• Hemophagocytic Lymphohistiocytosis Masquerading as Acute Liver Failure: A Single Center Experience.1 passage
• Hemorrhage and Rupture of an Unusual Benign Liver Lesion in Pregnancy: A Case Report.1 passage
• Hepatic Encephalopathy and Astrocyte Senescence.1 passage
• Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.1 passage
• Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients.1 passage
• Hepatic Glycogenoses Among Children-Clinical and Biochemical Characterization: Single-Center Study.1 passage
• Hepatic Sclerosing Hemangioma Simulating Gallbladder Carcinoma: A Rare Case.1 passage
• Hepatitis B Reactivation in Liver Transplant Recipients With Hepatitis B Virus Core Antibody Positive Grafts: a Retrospective Study.1 passage
• Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells.1 passage
• Hepatitis C Continuum of Care in a Treatment Center in Sub-Saharan Africa.1 passage
• Hepatitis C Virus Infection and Vaccine Development.1 passage
• Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India.1 passage
• Hepatitis E Virus Induced Acute Liver Failure with Scrub Typhus Coinfection in a Pregnant Woman.1 passage
• Hepatocellular Carcinoma Presenting as Dyspnea at Rest due to Innumerable Lung Metastasis.1 passage
• Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?1 passage
• Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.1 passage
• Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease.1 passage
• Hepatocellular Carcinoma: Etiology and Current and Future Drugs.1 passage
• Hepatogenous Diabetes: A Primer.1 passage
• Herbal Drugs: Friend or Foe?1 passage
• Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series.1 passage
• Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!1 passage
• High Prevalence of Cirrhosis at Initial Presentation Among Safety-Net Adults with Chronic Hepatitis B Virus Infection.1 passage
• Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers.1 passage
• Histological Evaluation of Non-alcoholic Fatty Liver Disease and Its Correlation with Different Noninvasive Scoring Systems with Special Reference to Fibrosis: A Single Center Experience.1 passage
• How to Design a Multicenter Clinical Trial in Hepatic Encephalopathy.1 passage
• Human Fascioliasis: Report of Two Cases from Kashmir Valley.1 passage
• Hyperammonemia in Hepatic Encephalopathy.1 passage
• INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids.1 passage
• INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.1 passage
• INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.1 passage
• Ideal Cure for Hepatitis B Infection: The Target is in Sight.1 passage
• Idiopathic Hypercalcemia in Decompensated Cirrhosis: Reexploring an Entity in Oblivion.1 passage
• If Hoofbeats are not From Horses, It Could be Zebras!! Isolated Hyper-alkaline Phosphatasemia.1 passage
• Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis.1 passage
• Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North India.1 passage
• Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India.1 passage
• Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.1 passage
• Impact of Vitamin D Status in Chronic Liver Disease.1 passage
• Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis.1 passage
• Incidence and Risk of Gallstone Disease in Gilbert's Syndrome Patients in Indian Population.1 passage
• Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.1 passage
• Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019.1 passage
• Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015.1 passage
• Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.1 passage
• Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure.1 passage
• Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.1 passage
• Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy.1 passage
• Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis.1 passage
• Innovative Approach of Using Esophageal Stent for Refractory Post-Band Ligation Esophageal Ulcer Bleed Following Living Donor Liver Transplantation.1 passage
• Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis.1 passage
• Intrahepatic cholangiocarcinoma masquerading as liver abscess.1 passage
• Is It Safe to Perform Endoscopic Retrograde Cholangiopancreatography in Decompensated Cirrhosis?1 passage
• Is Portal Venous Pressure or Porto-systemic Gradient Really A Harbinger of Poor Outcomes After Living Donor Liver Transplantation?1 passage
• Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.1 passage
• Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19.1 passage
• Late-Onset Peripheral T-Cell Lymphoma Not Otherwise Specified in a Liver Transplant Recipient: A Rare Subtype of Posttransplant Lymphoproliferative Disorder.1 passage
• Learning Gains of Liver Resection and Transplantation Workshop on Genelyn® Embalmed Human Cadavers: Surgical Gastroenterologists' Perceptions.1 passage
• Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.1 passage
• Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C Therapy.1 passage
• Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.1 passage
• Liver Transplant Society of India Guidelines for Liver Transplant during COVID-19 times.1 passage
• Liver Transplant in Acute Liver Failure - Looking Back Over 10 Years.1 passage
• Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First.1 passage
• Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus-Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus Development.1 passage
• Liver Transplantation for Acute Liver Failure in Presence of Acute Kidney Injury.1 passage
• Liver Transplantation for Acute on Chronic Liver Failure.1 passage
• Liver Transplantation for Alcohol-Related Liver Disease.1 passage
• Living Donor Liver Transplant in Patients Aged 60 Years or Older: Experience from a Large Volume Centre in India.1 passage
• Living Donor Liver Transplantation Using Small-for-Size Grafts: Does Size Really Matter?1 passage
• Living Donor Liver Transplantation for Acute on Chronic Liver Failure Based on EASL-CLIF Diagnostic Criteria.1 passage
• Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience from Pakistan.1 passage
• Living Donor Liver Transplantation in a Paediatric Patient With Citrullinaemia Type 2.1 passage
• Long Term Outcomes of Patients with Significant Biliary Obstruction Due to Portal Cavernoma Cholangiopathy and Extra-Hepatic Portal Vein Obstruction (EHPVO) With No Shuntable Veins.1 passage
• Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.1 passage
• Long-Term Outcomes of Liver Transplantation for Hepatic Sarcoidosis: A Single Center Experience.1 passage
• Long-term Management of the Adult Liver Transplantation Recipients.1 passage
• Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study.1 passage
• Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals.1 passage
• MHE Testing in Real World Scenario.1 passage
• Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians.1 passage
• Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians.1 passage
• Magnetic resonance imaging and spectroscopy in hepatic encephalopathy.1 passage
• Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.1 passage
• Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective.1 passage
• Malignant Hepatic Epithelioid Hemangioendothelioma with Villaret Syndrome.1 passage
• Management Patterns of Hepatic Encephalopathy: A Nationwide Survey in India.1 passage
• Management Practices and Predictors of Outcome of Liver Abscess in Adults: A Series of 1630 Patients from a Liver Unit.1 passage
• Management in acute liver failure.1 passage
• Management of Chronic Hepatitis B: Knowledge and Practices of Physicians in Pakistan.1 passage
• Management of covert hepatic encephalopathy.1 passage
• Management of overt hepatic encephalopathy.1 passage
• Matrix Metalloproteinases (MMPs) in Liver Diseases.1 passage
• Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure-A Pilot Study.1 passage
• Minimal hepatic encephalopathy impairs quality of life.1 passage
• Minimal/Covert Hepatic Encephalopathy - Impact of Comorbid Conditions.1 passage
• Molecular and Pathological Events Involved in the Pathogenesis of Diabetes-Associated Nonalcoholic Fatty Liver Disease.1 passage
• Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.1 passage
• Multifocal Intrahepatic Artery Aneurysm with FDG-avid Thrombosis Simulating Metastasis: Report of a Rare Case.1 passage
• Multiplex Reverse Transcriptase-PCR for Simultaneous Detection of Hepatitis B, C, and E Virus.1 passage
• Mutation in the Neuroblastoma Amplified Sequence Gene as a Cause of Recurrent Acute Liver Failure, Acute Kidney Injury, and Status Epilepticus.1 passage
• Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.1 passage
• Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.1 passage
• Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.1 passage
• Neonatal Cholestasis as Initial Presentation of Portosystemic Shunt: A Case Report.1 passage
• Neuroinflammation in hepatic encephalopathy: mechanistic aspects.1 passage
• Neurological Monitoring in Acute Liver Failure.1 passage
• Neurological Recovery After Recovery From Acute Liver Failure: Is it Complete?1 passage
• New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials.1 passage
• Non-Invasive Predictors for the First Variceal Hemorrhage in Children With Biliary Atresia After Kasai Portoenterostomy.1 passage
• Non-Wilson's Disease-Associated Hypoceruloplasminemia.1 passage
• Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.1 passage
• Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores.1 passage
• NonInvasive Biomarkers in Nonalcoholic Fatty Liver Disease: Are We There Yet?1 passage
• Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors.1 passage
• Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.1 passage
• Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.1 passage
• Nutrition and Muscle in Cirrhosis.1 passage
• Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.1 passage
• Optimal Duration of Pegylated Interferon Plus Ribavirin Therapy for Chronic Hepatitis C Genotype 3 Patients who do not Achieve Rapid Virological Response.1 passage
• Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding.1 passage
• Outcome of Living Donor Liver Transplantation for Wilson's Disease in Adults: A Single Center Experience.1 passage
• Outcome of Tyrosinemia Type 1 in Indian Children.1 passage
• Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.1 passage
• Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.1 passage
• Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation.1 passage
• Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort.1 passage
• PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.1 passage
• Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.1 passage
• Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.1 passage
• Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation.1 passage
• Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials.1 passage
• Patients With Budd-Chiari Syndrome Have Variable Coagulation Status on Thromboelastography at Diagnosis.1 passage
• Percutaneous Cryoablation of Liver Tumors: Initial Experience from a Tertiary Care Center in India.1 passage
• Percutaneous Drainage in Hepatic Hydatidosis-The PAIR Technique: Concept, Technique, and Results.1 passage
• Percutaneous Transhepatic Approach for Recanalization of Superior Mesenteric and Portal Vein in a Patient With Pancreatic Neuroendocrine Tumor Presenting With Bleeding Duodenal Varices: A Brief Case Report.1 passage
• Percutaneous Transhepatic Biliary Drainage for Biliary Stricture After Endotherapy Failure in Living Donor Liver Transplantation: A Single-Centre Experience from India.1 passage
• Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.1 passage
• Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification.1 passage
• Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.1 passage
• Polymorphisms in1 passage
• Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.1 passage
• Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation.1 passage
• Portal vein thrombosis.1 passage
• Potential Implications of Detecting HBsAg in Asymptomatic People in an Endemic Community Through Medical Camps.1 passage
• Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?1 passage
• Predictors of Successful Kasai Portoenterostomy and Survival with Native Liver at 2 Years in Infants with Biliary Atresia.1 passage
• Predictors of in-hospital outcomes in patients with Cirrhosis and Coronavirus disease-2019.1 passage
• Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience.1 passage
• Pregnancy After Liver Transplantation: Outcomes From a Single-Center Experience.1 passage
• Pregnancy and vascular liver disease.1 passage
• Prevalence and Characteristics of Hepatitis Delta Virus Infection in a Tertiary Hospital Setting in Cameroon.1 passage
• Prevalence and Impact of Bacterial Infections in Children With Liver Disease-A Prospective Study.1 passage
• Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.1 passage
• Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.1 passage
• Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.1 passage
• Prevalence of and Factors Associated with Sleep-Wake Abnormalities in Patients with Cirrhosis.1 passage
• Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation.1 passage
• Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.1 passage
• Primary Hepatic Burkitt Lymphoma: A Bizarre Site and Triumph Tale.1 passage
• Primary Liver Sinusoidal Non-Hodgkin's Lymphoma Presenting as Acute Liver Failure.1 passage
• Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.1 passage
• Profile of Hepatobiliary Dysfunction in Hematopoietic Stem Cell Transplant Recipients - An Indian Perspective.1 passage
• Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies.1 passage
• Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome.1 passage
• Psychiatric Morbidity, Fatigue, Stigma and Quality of Life of Patients With Hepatitis B Infection.1 passage
• Pyoderma Gangrenosum-A New Manifestation of Wilson Disease?1 passage
• Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.1 passage
• Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement.1 passage
• Radiological Intervention for Shunt Related Encephalopathy.1 passage
• Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome.1 passage
• Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.1 passage
• Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease.1 passage
• Recognizing dysfunctional innate and adaptive immune responses contributing to liver damage in patients with cirrhosis.1 passage
• Recurrent Hepatic Encephalopathy Due to Surgically Created Shunt During Living Donor Liver Transplantation.1 passage
• Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis-A Case Report.1 passage
• Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.1 passage
• Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males.1 passage
• Relative Adrenal Insufficiency in Patients with Alcoholic Hepatitis.1 passage
• Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice.1 passage
• Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease.1 passage
• Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.1 passage
• Restructuring Living-Donor Liver Transplantation at a High-Volume Center During the COVID-19 Pandemic.1 passage
• Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.1 passage
• Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.1 passage
• Retrohepatic Caval Leiomyosarcoma Antesitum Resection: A Case Report and a Review of Literature.1 passage
• Revisiting the Surgical Management of Giant Hepatic Hemangiomas: Enucleation Versus Anatomical Resection?1 passage
• Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case-Control Study.1 passage
• Rolandic Epilepsy as a Heralding Manifestation of Wilson Disease in a 6-Year-Old Girl.1 passage
• Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review.1 passage
• Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study.1 passage
• Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance Spectroscopy.1 passage
• Role of Exercise in the Management of Hepatic Encephalopathy: Experience From Animal and Human Studies.1 passage
• Role of Glutathione S Transferase M1 and T1 Gene Polymorphism in Hepatitis B Related Liver Diseases and Cryptogenic Cirrhosis.1 passage
• Role of Granulocyte Colony Stimulating Factor on the Short-Term Outcome of Children with Acute on Chronic Liver Failure.1 passage
• Role of Indocyanine Green in Predicting Post-Transarterial Chemoembolization Liver Failure in Hepatocellular Carcinoma.1 passage
• Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index.1 passage
• Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center Experience.1 passage
• Role of Peripheral Inflammation in Hepatic Encephalopathy.1 passage
• Role of Transient Elastography (Fibroscan) in Differentiating Severe Acute Hepatitis and Acute on Chronic Liver Failure.1 passage
• Rupture of Hepatocellular Carcinoma: A Review of Literature.1 passage
• SARS-CoV-2 infection in Liver Transplant recipients - Immunosuppression is the silver lining?1 passage
• Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major.1 passage
• Safety of Ascitic Paracentesis in Patients with Budd-Chiari Syndrome on Oral Anticoagulation and Elevated International Normalized Ratio.1 passage
• Salvage Balloon Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleed in Cirrhotic Patients With Endoscopic Failure to Control Bleed/Very Early Rebleed: Long-term Outcomes.1 passage
• Sarcopenia in Cirrhosis: Fallout on Liver Transplantation.1 passage
• Scores of Child-Pugh Classification Impact Overall Survival After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors.1 passage
• Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?1 passage
• Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?1 passage
• Sepsis Following Liver Biopsy in a Liver Transplant Recipient: Case Report and Review of Literature.1 passage
• Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis.1 passage
• Sickle Hepatopathy.1 passage
• Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.1 passage
• Simple Anthropometric Indices are Useful for Predicting Non-alcoholic Fatty Liver Disease [NAFLD] in Asian Indians.1 passage
• Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.1 passage
• Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India.1 passage
• Sofosbuvir and Ribavirin for 24 Weeks Is An Effective Treatment Option for Recurrent Hepatitis C Infection After Living Donor Liver Transplantation.1 passage
• Sofosbuvir-Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation.1 passage
• Spontaneous Bacterial Peritonitis by1 passage
• Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience.1 passage
• Structural and Epitope Analysis (T- and B-Cell Epitopes) of Hepatitis C Virus (HCV) Glycoproteins: An1 passage
• Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D Supplementation.1 passage
• Study of the effects of cyclooxygenase-2 inhibitor on the promotion of hepatic tumorigenesis in rats fed a high fat diet.1 passage
• Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience.1 passage
• Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab.1 passage
• Survival and Outcome in Patients Receiving Drug-Eluting Beads Transarterial Chemoembolization for Large Hepatocellular Carcinoma (>5 cm).1 passage
• Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.1 passage
• Synchronous Gall Bladder and Bile Duct Cancer: A Short Series of Seven Cases and a Brief Review of Literature.1 passage
• Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field.1 passage
• Tackling the Hepatitis C Disease Burden in Punjab, India.1 passage
• Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.1 passage
• Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction.1 passage
• Tenofovir is Superior to Entecavir in Patients with Treatment-naïve Hepatitis B e-Antigen-Positive Chronic Hepatitis B.1 passage
• The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.1 passage
• The Changing Face of Hepatocellular Carcinoma: Forecasting Prevalence of Nonalcoholic Steatohepatitis and Hepatitis C Cirrhosis.1 passage
• The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data.1 passage
• The Current Hepatic Encephalopathy Pipeline.1 passage
• The Discovery of Hepatitis Viruses: Agents and Disease.1 passage
• The Impact of Ethnic Subgroups on Tumor Stage at Diagnosis, Treatment Received, and Long-Term Survival Among Asian Adults With Hepatocellular Carcinoma.1 passage
• The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.1 passage
• The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.1 passage
• The Outcome after Hospital Discharge in Cirrhosis is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis.1 passage
• The Outcome of Primary Hepatic Neuroendocrine Tumors: A Single-Center Experience.1 passage
• The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.1 passage
• The Preliminary Study on Procurement Biliary Convergence from Donors with Complicated Bile Duct Variant in Emergency Right Lobe Living Donor Liver Transplantation.1 passage
• The Protective Effect of Zinc Against Liver Ischaemia Reperfusion Injury in a Rat Model of Global Ischaemia.1 passage
• The Use of a 3D Printing Model in Planning a Donor Hepatectomy for Living Donor Liver Transplantation: First in India.1 passage
• The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy.1 passage
• Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.1 passage
• Thromboelastography for Assessing the Risk of Bleeding in Patients With Cirrhosis-Moving Closer.1 passage
• Tobacco, Cigarettes, and the Liver: The Smoking Gun.1 passage
• Toward a Better Definition of Acute-on-Chronic Liver Failure.1 passage
• Transient Elastography (Fibroscan) in Patients with Non-cirrhotic Portal Fibrosis.1 passage
• Treatment Armamentarium of COVID-19: Evolving Strategies and Evidence So Far.1 passage
• Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study.1 passage
• Undiagnosed Hepatic Tuberculosis Presenting With Intraabdominal Rupture and Hemoperitoneum, Requiring Urgent Hepatic Resection.1 passage
• Universal HCV Screening of Baby Boomers is Feasible, but It is Difficult.1 passage
• Unusual Presentation of Systemic Lupus Erythematosus in a Young Male: A Case Report.1 passage
• Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult.1 passage
• Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.1 passage
• Vascular Endothelial Growth Factor Promotes Proliferation of Epithelial Cell Adhesion Molecule-Positive Cells in Nonalcoholic Steatohepatitis.1 passage
• What Are the Current Pharmacological Therapies for Nonalcoholic Fatty Liver Disease?1 passage
• Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.1 passage
• Wilson Disease Presenting With Acute on Chronic Liver Failure: A Single-Center Experience of Outcome and Predictors of Mortality in 68 Patients.1 passage
• Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India.1 passage